Express your opinion about this website:
Traffic report about valcyte.com - here you can find answers to questions like these:
Our system has never spotted valcyte.com in Alexa ratings.
This fact suggests that domain has very low traffic.
The most recent time we have spotted valcyte.com on Quantcast list was on February 6, 2014 (3,742 days ago) and then the rank was 802,882. And this is a bit better position than average position for valcyte.com in Quantcast.
Website is hosted on IP 72.34.128.99.
The host name of this IP address is cmvdiseasetherapy.com.
There are 1 websites hosted on exact the same IP and 87 websites that are hosted on similar IP address.
We have no data about websites that could be similar to valcyte.com.
We've checked valcyte.com recently and it was online. The load time was 0.0728 seconds slower than average. The size of document was 25,548 bytes shorter than usually. The website contained 67 links less than the average.
We have no information if valcyte.com is optimised for mobile devices.
We did not encounter any safety threats while testing this website.
We did not find any data about valcyte.com being listed in the blacklists.
It seems that valcyte.com was never dropped before.
Click here to see the list of dropped domains
Our system found out that there could be 291 domains with the same beginning as valcyte.com
Our system found out that there could be 40 mistakes made in the typing process.
And here you'll find analysis of HTML code:
PROPERTY | VALUE |
---|---|
Keywords: | valcyte, valcyte cost, valganciclovir hydrochloride, cytomegalovirus, cytomegalovirus antiviral, CMV, transplant, GTAS, patient financial support, patient assistance, co-pay card, antiviral, cmv virus, organ transplants, Genentech, genentech transplant access services, generic valcyte |
WEB address: | http://valcyte.com/ |
Summary: | Learn how to reduce Valcyte® (valganciclovir hydrochloride) costs and how Valcyte antiviral medication can help prevent CMV disease in transplant patients. Indications. Adult patients: Valcyte® (valganciclovir hydrochloride) tablets are an antiviral prescription medication given to patients who have a high chance of developing cytomegalovirus (CMV) disease after receiving a heart, kidney, or kidney‐pancreas transplant. Valcyte helps prevent CMV disease in these patients. Pediatric Patients: Valcyte tablets or oral solution is prescribed for the prevention of CMV disease in patients that are 4 months to 16 years of age who have received a kidney transplant or in patients that are 1 month to 16 years of age who have received a heart transplant and have a high chance of developing CMV disease. Important Safety Information and Most Serious Side Effects. Valcyte can affect blood cells and bone marrow causing serious and life‐threatening problems. Patients’ doctors may do regular blood tests to check blood cells and may change the dose or tell patients to stop taking Valcyte. Patients must tell their doctor right away if they have any unexpected bruising or bleeding, unusual tiredness, fever, lack of energy, dizziness, or fainting. Valcyte may cause cancer. Valcyte causes cancer in animals. It is not known if Valcyte causes cancer in people. Valcyte may cause birth defects. Pregnant women who take Valcyte have a higher chance of having a baby with birth defects. Valcyte should not be used during pregnancy. Women who can get pregnant must use a reliable method of birth control during treatment with Valcyte and continue birth control for at least 30 days after they stop taking Valcyte. Women must tell their doctor right away if they get pregnant or plan to become pregnant while taking Valcyte. Men must use a condom during treatment with Valcyte, and for at least 90 days after treatment, if their partner can get pregnant. Patients should talk to their doctor if they have questions about birth control. Valcyte may lower the amount of sperm in a man’s body and cause fertility problems. Valcyte may also cause fertility problems in women. Do not take Cytovene‐IV if you are taking VALCYTE. You could overdose and become very sick if VALCYTE is taken with Cytovene‐IV. Talk to your healthcare provider or pharmacist if you have questions about your medicine. Patients should not receive Valcyte if they are allergic to any of its ingredients or if they have ever had a serious reaction to ganciclovir capsules or Cytovene‐IV. Symptoms of an allergic reaction to Valcyte may include cold, sudden trouble breathing, wheezing, hives all over the body, swelling around the mouth, or feeling anxious. Valcyte can affect the kidneys, including serious problems such as kidney failure. The patient’s doctor may do regular blood tests to check kidney function while patients are taking Valcyte. The doctor may adjust the dose based on these tests. Patients must not take Valcyte tablets if they are receiving hemodialysis. Patients should talk to their doctor if they are receiving hemodialysis. Before starting Valcyte, patients should tell their doctor if they: are pregnant or plan to become pregnant. It is not known if Valcyte causes birth defects in an unborn baby, are breast feeding, or plan to breast feed, have kidney problems or any other medical condition, have problems with their blood cells, are taking any prescription or non‐prescription medicines, vitamins, and herbal supplements, are having radiation treatment, are receiving hemodialysis. Valcyte can cause seizures, sleepiness, dizziness, unsteady movements, and confusion. Patients should not drive a car or operate other dangerous machinery until they know how Valcyte affects them. Patients must take Valcyte exactly as their doctor prescribes it. Adult patients should use Valcyte tablets, not Valcyte for oral solution. Valcyte must be taken with food. Do not break or crush tablets. Common side effects of Valcyte in adults and children include: diarrhea, nausea, vomiting, fever, shaky movements (tremors), low blood cell counts in a blood test, and rejection of the transplanted organ (graft). Other common side effects in children include: headache, upper respiratory tract infection, high blood pressure, and urinary tract infection. Patients should tell their doctor if they have any side effect that bothers them or that does not go away. Patients should call their doctor for medical advice about side effects. Consumers may report side effects to the FDA at 1‐800‐FDA‐1088 or to Genentech at 1‐888‐835‐2555. Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide, for additional Important Safety Information. |
<title> | Valcyte® (valganciclovir hydrochloride) Patient Support |
Hosting information: | Click here for more hosting information |
Size of HTML code: | -25,548 bytes compared to average |
Total number of links: | -67 links compared to average |
Load time: | +0.07279435 seconds compared to average |
No data about Alexa yet.
This table shows websites that use 72.34.128.99 (cmvdiseasetherapy.com) for hosting:
List of websites | IP address and hostname |
---|---|
72.34.128.99 cmvdiseasetherapy.com |
Note: The matching part of IP address is marked with this style.
Website: | valcyte.com |
---|---|
Most recent position: | 802,882 reached on February 6, 2014 (3,742 days ago) |
Times found in quant list: | 156 |
Average position: | 502,954 |
All time highest position: | 132,819 reached on January 7, 2014 (3,772 days ago) |
All time lowest position: | 804,619 reached on January 31, 2014 (3,748 days ago) |
There are 291 alternatives to valcyte.com
We believe that these mistakes can be made in the typing process of "valcyte.com":
No data about valcyte.com being in dropped domains database...